EGF and breast carcinoma: Inhibition of Rac1 by ZINC69391 was also associated with reduced epidermal growth factor (EGF)-mediated Rac1 activation and efficient inhibition of cell proliferation, cell cycle progression and cell migration in highly metastatic breast cancer cell lines.